Sign in

CIK 0001724521

  • Large accelerated filer

Arcus Biosciences, Inc.

Sign in to watch
Ticker
RCUS
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
473898435
Phone
+1 510-694-6200
Business address
3928 POINT EDEN WAY, HAYWARD, CA, 94545
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$84,810
in 1 filing, $85K under 10b5-1 plans

Net −$84,810. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Azoy Alexander −$85K Chief Accounting Officer sold 7% of stake

Reading 59 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-04-23 Grossman William Chief Medical Officer Sale −4,133 $31.37 $130K 6,717
2021-03-31 FALBERG KATHRYN E Director Purchase +20,000 $28.35 $567K 102,106
2021-03-16 Grossman William Chief Medical Officer Sale −2,127 $35.03 $75K 10,850
2021-03-16 Jarrett Jennifer Chief Operating Officer Sale −8,661 $35.03 $303K 116,973
2021-02-01 ROSEN TERRY J Chief Executive Officer Gift −311,900 0
2021-01-31 GILEAD SCIENCES INC 10% owner Purchase +5,650,000 $39.00 $220.3M 13,913,029
2021-01-19 Tang Carolyn C. General Counsel Grant or award +12,538 19,886
2021-01-19 Tang Carolyn C. General Counsel Grant or award · Stock Option (right to buy) +75,225 75,225
2021-01-19 ROSEN TERRY J Chief Executive Officer Grant or award +45,000 234,393
2021-01-19 ROSEN TERRY J Chief Executive Officer Grant or award · Stock Option (right to buy) +280,000 280,000
2021-01-19 Jarrett Jennifer Chief Operating Officer Grant or award +400,000 500,634
2021-01-19 Jaen Juan C. President Grant or award +19,375 208,768
2021-01-19 Jaen Juan C. President Grant or award · Stock Option (right to buy) +116,250 116,250
2021-01-19 Grossman William Chief Medical Officer Grant or award +18,750 25,477
2021-01-19 Grossman William Chief Medical Officer Grant or award · Stock Option (right to buy) +112,500 112,500
2021-01-19 Goeltz II Robert C. Chief Financial Officer Grant or award +12,500 17,500
2021-01-19 Goeltz II Robert C. Chief Financial Officer Grant or award · Stock Option (right to buy) +75,000 75,000
2020-12-17 PERLMAN ANDREW J Director Grant or award +4,500 4,500
2020-12-17 PERLMAN ANDREW J Director Grant or award · Stock Option (Right to Buy) +21,000 21,000
2020-12-16 Grossman William Chief Medical Officer Sale −2,117 $31.35 $66K 6,727

Page 19 of 20 · 381 trades